Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1099 | 990 | 1168 | - | - | - |
| Fund Return | 9.88% | -1% | 16.8% | - | - | - |
| Place in category | 702 | 1021 | 564 | - | - | - |
| % in Category | 30 | 42 | 25 | - | - | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| LU0996175948 | 10.32B | 21.13 | 20.97 | 7.89 | ||
| LU0996177217 | 10.32B | 20.89 | 20.66 | 7.65 | ||
| Amundi Index MSCI EM IE-D | 10.32B | 21.14 | 20.96 | 7.92 | ||
| First Eagle Amundi Intl Fund Classe | 10.25B | 12.16 | 15.24 | 7.83 | ||
| LU0433182416 | 10.25B | 4.95 | 14.99 | 5.21 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Eleva Euro Slct Class R EUR Acc | 9.5B | 8.78 | 17.86 | 10.84 | ||
| Eleva Euro Slct Class A2 EUR Acc | 9.5B | 7.81 | 16.75 | 9.75 | ||
| Eleva Euro Slct Class A1 EUR Acc | 9.5B | 8.23 | 15.75 | 10.36 | ||
| Eleva Euro Slct Class I EUR Acc | 9.5B | 8.83 | 17.89 | 10.92 | ||
| Amundi MSCI Euro IE D | 8.45B | 12.79 | 17.40 | 9.64 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| ASML Holding | NL0010273215 | 4.56 | 1,298.20 | +1.14% | |
| Roche Holding Participation | CH1499059983 | 2.47 | 393.90 | +0.92% | |
| HSBC | GB0005405286 | 2.30 | 1,316.60 | +0.92% | |
| Shell | GB00BP6MXD84 | 2.27 | 44.47 | -0.60% | |
| Novartis | CH0012005267 | 2.07 | 133.90 | +0.62% |
| Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | - | - | - | Buy | Buy |
| Technical Indicators | - | - | - | Strong Buy | BUY |
| Summary | Neutral | Neutral | Neutral | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review